15
SNU-398細(xì)胞， 人肝癌細(xì)胞
| ATCC® Number: | CRL-2233™ | Price: | $417.00 |
| Designations:SNU-398Depositors:J ParkBiosafety Level:2 [CELLS CONTAIN HEPATITIS B VIRUS ]Shipped:frozenMedium & Serum:See PropagationGrowth Properties:mixed adherent and floatingOrganism:Homo sapiens (human)Morphology:epithelial Source:Organ: liver Disease: hepatocellular carcinomaPermits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.SNU-398細(xì)胞， 人肝癌細(xì)胞Restrictions:This line is available under the following restrictions: 1.) The cell line was deposited for research purposes only. Neither the cell line nor products derived from it may be sold or used for commercial purposes. Nor can the cells be distributed to third parties for purpose of sale, or producing for sale, cells or their products. The cells are provided as a service to the research community. They are provided without warranty or merchantability of fitness for a particular purpose or any other warranty, express or implied. 2.) Any proposed commercial use of these cells or products produced by them must first be negotiated with Jae-GaHB-Park, Director, Korean Cell Line Bank, 28 Yongon-dong, Chongno-gu, Seoul, 110-744 Korea. ephone (02) 760-3380, (02) 742-4727. 3.) In all papers reporting any use of these cells or derived products, a direct reference will be made to the original publication (Int. J. Cancer 62:276-282, 1995).Antigen Expression:Blood Type O; Rh +DNA Profile (STR):Amelogenin: X,Y CSF1PO: 13 D13S317: 11 D16S539: 10,14 D5S818: 12 D7S820: 10,11 THO1: 7,9 TPOX: 11 vWA: 17,18Cytogenetic Analysis:aneuploid; modal number = 62Age:42 yearsGender:maleEthnicity:AsianComments:Preservation:Culture medium, 95%; DMSO, 5%Doubling Time:39 hrsReferences:22872: Park JG, et al. Characterization of cell lines established from human hepatocellular carcinoma. Int. J. Cancer 62: 276-282, 1995. PubMed:7543080 | |||
